Akt1 deletion prevents lung tumorigenesis by mutant K-ras

作者: M C Hollander , C R Maier , E A Hobbs , A R Ashmore , R I Linnoila

DOI: 10.1038/ONC.2010.556

关键词:

摘要: K-ras mutations are associated with smoking-induced lung cancer and poor clinical outcomes. In mice, sufficient to induce tumors, which require phosphoinoside-3-kinase (PI3K) further downstream, mammalian target of rapamycin (mTOR) activation. However, the roles individual Akt isoforms that link PI3K mTOR unknown. Here, we show deletion Akt1 but not Akt2 or Akt3 prevents tumorigenesis in a tobacco carcinogen-induced model genetic model. prevented tumor initiation as well progression, coincident decreased signaling tissues. contrast, increased multiplicity carcinogen size Fibroblasts lacking resistant transformation by mutant stimulation epidermal growth factor. Human cells diminished levels fail grow vivo. These data suggest is primary isoform activated may oppose progression. Given inhibitors development therapeutics selective, these studies support specific targeting mitigate effects cancer.

参考文章(49)
J. Cicenas, The potential role of Akt phosphorylation in human cancers. International Journal of Biological Markers. ,vol. 23, pp. 1- 9 ,(2008) , 10.5301/JBM.2008.618
Susan Swift, James Lorens, Philip Achacoso, Garry P. Nolan, Rapid Production of Retroviruses for Efficient Gene Delivery to Mammalian Cells Using 293T Cell–Based Systems Current protocols in immunology. ,vol. 31, ,(1999) , 10.1002/0471142735.IM1017CS31
Mary Christine Hollander, Andria R. Balogh, Jaminelli Liwanag, Wei Han, Ritva Ilona Linnoila, Miriam R. Anver, Phillip A. Dennis, Strain-specific spontaneous and NNK-mediated tumorigenesis in Pten+/- mice. Neoplasia. ,vol. 10, pp. 866- 872 ,(2008) , 10.1593/NEO.08406
M. Christine Hollander, M. Saeed Sheikh, Dmitry V. Bulavin, Karen Lundgren, Laura Augeri-Henmueller, Ronald Shehee, Thomas A. Molinaro, Kate E. Kim, Eva Tolosa, Jonathan D. Ashwell, Michael P. Rosenberg, Qimin Zhan, Pedro M. Fernández-Salguero, William F. Morgan, Chu-Xia Deng, Albert J. Fornace, Genomic instability in Gadd45a- deficient mice Nature Genetics. ,vol. 23, pp. 176- 184 ,(1999) , 10.1038/13802
Leisa Johnson, Kim Mercer, Doron Greenbaum, Roderick T. Bronson, Denise Crowley, David A. Tuveson, Tyler Jacks, Somatic activation of the K-ras oncogene causes early onset lung cancer in mice Nature. ,vol. 410, pp. 1111- 1116 ,(2001) , 10.1038/35074129
R Khosravi-Far, M A White, J K Westwick, P A Solski, M Chrzanowska-Wodnicka, L Van Aelst, M H Wigler, C J Der, Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Molecular and Cellular Biology. ,vol. 16, pp. 3923- 3933 ,(1996) , 10.1128/MCB.16.7.3923
J M Askham, F Platt, P A Chambers, H Snowden, C F Taylor, M A Knowles, AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K. Oncogene. ,vol. 29, pp. 150- 155 ,(2010) , 10.1038/ONC.2009.315
Gavin P. Robertson, Functional and therapeutic significance of Akt deregulation in malignant melanoma. Cancer and Metastasis Reviews. ,vol. 24, pp. 273- 285 ,(2005) , 10.1007/S10555-005-1577-9
Brendan D. Manning, Lewis C. Cantley, AKT/PKB signaling: navigating downstream. Cell. ,vol. 129, pp. 1261- 1274 ,(2007) , 10.1016/J.CELL.2007.06.009
Donatella Malanga, Marianna Scrima, Carmela De Marco, Fernanda Fabiani, Nicola De Rosa, Silvia de Gisi, Natalia Malara, Rocco Savino, Gaetano Rocco, Gennaro Chiappetta, Renato Franco, Virginia Tirino, Giuseppe Pirozzi, Giuseppe Viglietto, Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung. Cell Cycle. ,vol. 7, pp. 665- 669 ,(2008) , 10.4161/CC.7.5.5485